New York, USA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight The exosome market is fueled by several significant factors, such as the rising incidence of chronic diseases, improvements in diagnostic methods, and heightened interest in personalized medicine. Exosomes' potential as biomarkers for numerous conditions adds to their value in research and clinical settings.
Moreover, growing investments in the biotech and pharmaceutical sectors, coupled with partnerships between academic and commercial organizations, are further accelerating market expansion. DelveInsight’s Exosome Market Insights report provides the current and forecast market analysis, individual leading Exosome companies’ market shares, challenges, Exosome market drivers, barriers, trends, and key market Exosome companies in the market. Key Takeaways from the Exosome Market Report As per DelveInsight estimates, North America is anticipated to dominate the global Exosome market during the forecast period.
In the product type segment of the exosome market, the kits and reagents category is projected to capture a substantial revenue share in the coming years. Notable Exosome companies such as Danaher, Thermo Fisher Scientific Inc., QIAGEN, Hologic, Bio-Techne.
, Takara Bio Inc., FUJIFILM Corporation, Miltenyi Biotec, Lonza., JSR Corporation.
, System Biosciences, LLC., Malvern Panalytical Ltd., Norgen Biotek Corp.
, Cell Guidance Systems Ltd., .
